Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.044 USD | -2.22% | -3.61% | -34.71% |
Mar. 28 | Arcadia Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 28 | Transcript : Arcadia Biosciences, Inc., Q4 2023 Earnings Call, Mar 28, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-34.71% | 2.85M | |
+15.82% | 38.38B | |
-.--% | 11.15B | |
-4.50% | 7.3B | |
+6.68% | 6.87B | |
-3.91% | 5.91B | |
-10.60% | 5.6B | |
-4.54% | 5.54B | |
+33.14% | 5.19B | |
-13.69% | 4.58B |
- Stock Market
- Equities
- RKDA Stock
- News Arcadia Biosciences, Inc.
- Arcadia Biosciences : HC Wainwright Adjusts Arcadia Biosciences' Price Target to $10 from $12, Keeps Buy Rating